Travere Therapeutics Inc (TVTX) Insider Trading
Total insider buys:
- $0.00
Total insider sells:
- $27,988,484.69
Most recent insider trade:
- April 22, 2026
Most active insider trader:
- Christopher R Cline
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Jan. 31, 2022 | CFO | 1,238 | $27.40 | Sell | $33,921.20 | |
| Jan. 31, 2022 | CEO | 4,813 | $27.40 | Sell | $131,876.20 | |
| Jan. 31, 2022 | SVP | 1,350 | $27.40 | Sell | $36,990.00 | |
| Jan. 24, 2022 | CEO | 7,873 | $24.98 | Sell | $196,667.54 | |
| Jan. 24, 2022 | SVP | 1,875 | $24.98 | Sell | $46,837.50 | |
| Jan. 24, 2022 | CAO | 934 | $24.58 | Sell | $22,957.72 | |
| Jan. 24, 2022 | CFO | 2,063 | $24.98 | Sell | $51,533.74 | |
| Jan. 11, 2022 | SVP | 5,000 | $27.40 | Sell | $137,000.00 | |
| Jan. 11, 2022 | CFO | 7,500 | $27.40 | Sell | $205,500.00 | |
| Jan. 4, 2022 | CEO | 4,832 | $30.43 | Sell | $147,037.76 | |
| Nov. 16, 2021 | Director | 31,800 | $29.39 | Sell | $934,602.00 | |
| Nov. 5, 2021 | Director | 10,000 | $26.23 | Sell | $262,300.00 | |
| Oct. 7, 2021 | Director | 60,000 | $26.25 | Sell | $1,575,000.00 | |
| Aug. 17, 2021 | Insider | 1,407 | $17.12 | Sell | $24,087.84 | |
| Aug. 17, 2021 | CEO | 7,836 | $17.12 | Sell | $134,152.32 | |
| July 28, 2021 | Insider | 1,250 | $13.81 | Sell | $17,262.50 | |
| June 2, 2021 | CEO | 9,562 | $14.62 | Sell | $139,796.44 | |
| April 16, 2021 | Director | 10,000 | $26.23 | Sell | $262,300.00 | |
| March 17, 2021 | Director | 17,727 | $27.44 | Sell | $486,428.88 | |
| Feb. 18, 2021 | SVP | 2,500 | $28.01 | Sell | $70,025.00 | |
| Feb. 3, 2021 | Insider | 1,813 | $28.91 | Sell | $52,413.83 | |
| Feb. 3, 2021 | CFO | 3,625 | $28.91 | Sell | $104,798.75 | |
| Feb. 3, 2021 | CEO | 2,406 | $28.91 | Sell | $69,557.46 | |
| Feb. 3, 2021 | SVP | 3,175 | $28.91 | Sell | $91,789.25 |
Insiders are selling Travere Therapeutics Inc stock.
The insider traders at Travere Therapeutics Inc are: Christopher R Cline, Eric M Dube, Sandra Calvin, Peter Heerma, William E Rote, Elizabeth E Reed, Jula Inrig, Steve Aselage, Laura Clague, Roy D Baynes, Gary A Lyons, Noah L. Rosenberg, Jeffrey A Meckler, and Noah L Rosenberg
The most active insider trader at Travere Therapeutics Inc is Christopher R Cline with 21 trades.
Eric M Dube has sold the most Travere Therapeutics Inc stock with a total value of $12,197,988.23.
The most recent insider trade for Travere Therapeutics Inc was on April 22, 2026.
The single biggest insider sell for Travere Therapeutics Inc was from Eric M Dube with a total value of $3,230,808.36 on Feb. 3, 2026.